欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/1070/001
药品名称Carmustine Accord
活性成分
    • carmustine 100.0 mg
剂型Powder and solvent for concentrate for solution for infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV UTRECHT NL
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
      Carmustine Accord
    • Estonia (EE)
    • Germany (DE)
      Carmustine Accord 100 mg Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
    • Cyprus (CY)
      Carmustine Accord 100mg powder and solvent for solution for infusion
    • Denmark (DK)
      Carmustine
    • Czechia (CZ)
      Carmustine Accord 100 mg prášek a rozpouštědlo pro infuzní roztok
    • Netherlands (NL)
      Carmustine Accord 100 mg Poeder en oplosmiddel voor oplossing voor infusie
    • Malta (MT)
    • Ireland (IE)
许可日期2021/12/09
最近更新日期2024/04/09
药物ATC编码
    • L01AD01 carmustine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase